Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001213900-15-008727
Filing Date
2015-11-16
Accepted
2015-11-16 16:21:37
Documents
1
Period of Report
2015-11-12

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT f3111215shenouda_relmadather.html 3  
1 OWNERSHIP DOCUMENT f3111215shenouda_relmadather.xml 3 2995
  Complete submission text file 0001213900-15-008727.txt   4442
Mailing Address 546 FIFTH AVENUE, 14TH FLOOR NEW YORK NY 10036
Business Address 546 FIFTH AVENUE, 14TH FLOOR NEW YORK NY 10036 212-702-7163
RELMADA THERAPEUTICS, INC. (Issuer) CIK: 0001553643 (see all company filings)

EIN.: 455401931 | State of Incorp.: NV | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations

Mailing Address 305 WEST 18TH STREET, APT 4B NEW YORK NY 10011
Business Address
Shenouda Maged (Reporting) CIK: 0001658369 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-55347 | Film No.: 151234819